Alps Advisors Inc Royalty Pharma PLC Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $1,628 - $1,853	-62 Reduced 0.54%	11,488 $302,000
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $317,163 - $361,861	11,550 New	11,550 $350,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $261,364 - $305,479	-7,232 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$42.34 - $52.82 $306,202 - $381,994	7,232 New	7,232 $315,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.